nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—CYP1A2—Dacarbazine—pancreatic cancer	0.086	0.327	CbGbCtD
Rizatriptan—CYP1A2—Tamoxifen—pancreatic cancer	0.0684	0.26	CbGbCtD
Rizatriptan—CYP1A2—Erlotinib—pancreatic cancer	0.0582	0.221	CbGbCtD
Rizatriptan—CYP1A2—Fluorouracil—pancreatic cancer	0.0504	0.192	CbGbCtD
Rizatriptan—Dyspepsia—Fluorouracil—pancreatic cancer	0.000532	0.001	CcSEcCtD
Rizatriptan—Nausea—Tamoxifen—pancreatic cancer	0.000531	0.001	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000531	0.001	CcSEcCtD
Rizatriptan—Fatigue—Gemcitabine—pancreatic cancer	0.00053	0.001	CcSEcCtD
Rizatriptan—Gastritis—Epirubicin—pancreatic cancer	0.00053	0.000999	CcSEcCtD
Rizatriptan—Muscular weakness—Epirubicin—pancreatic cancer	0.000528	0.000996	CcSEcCtD
Rizatriptan—Pain—Gemcitabine—pancreatic cancer	0.000526	0.000992	CcSEcCtD
Rizatriptan—Constipation—Gemcitabine—pancreatic cancer	0.000526	0.000992	CcSEcCtD
Rizatriptan—Nausea—Erlotinib—pancreatic cancer	0.000526	0.000992	CcSEcCtD
Rizatriptan—Decreased appetite—Fluorouracil—pancreatic cancer	0.000525	0.000991	CcSEcCtD
Rizatriptan—Diarrhoea—Sunitinib—pancreatic cancer	0.000524	0.000989	CcSEcCtD
Rizatriptan—Dysgeusia—Docetaxel—pancreatic cancer	0.000523	0.000987	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000522	0.000984	CcSEcCtD
Rizatriptan—Abdominal distension—Epirubicin—pancreatic cancer	0.000521	0.000983	CcSEcCtD
Rizatriptan—Ataxia—Doxorubicin—pancreatic cancer	0.000521	0.000982	CcSEcCtD
Rizatriptan—Feeling abnormal—Irinotecan—pancreatic cancer	0.00052	0.000981	CcSEcCtD
Rizatriptan—Dysphagia—Epirubicin—pancreatic cancer	0.000517	0.000976	CcSEcCtD
Rizatriptan—Pain—Fluorouracil—pancreatic cancer	0.000517	0.000975	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000516	0.000973	CcSEcCtD
Rizatriptan—Dehydration—Doxorubicin—pancreatic cancer	0.000515	0.000972	CcSEcCtD
Rizatriptan—Muscle spasms—Docetaxel—pancreatic cancer	0.000514	0.000969	CcSEcCtD
Rizatriptan—Dizziness—Sunitinib—pancreatic cancer	0.000507	0.000956	CcSEcCtD
Rizatriptan—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000507	0.000956	CcSEcCtD
Rizatriptan—Angina pectoris—Epirubicin—pancreatic cancer	0.000504	0.000951	CcSEcCtD
Rizatriptan—Abdominal pain—Irinotecan—pancreatic cancer	0.000499	0.000941	CcSEcCtD
Rizatriptan—Body temperature increased—Irinotecan—pancreatic cancer	0.000499	0.000941	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000499	0.000941	CcSEcCtD
Rizatriptan—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000498	0.000939	CcSEcCtD
Rizatriptan—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000495	0.000934	CcSEcCtD
Rizatriptan—Gastritis—Doxorubicin—pancreatic cancer	0.00049	0.000925	CcSEcCtD
Rizatriptan—Muscular weakness—Doxorubicin—pancreatic cancer	0.000489	0.000922	CcSEcCtD
Rizatriptan—Vomiting—Sunitinib—pancreatic cancer	0.000487	0.000919	CcSEcCtD
Rizatriptan—Body temperature increased—Gemcitabine—pancreatic cancer	0.000486	0.000917	CcSEcCtD
Rizatriptan—Dysuria—Epirubicin—pancreatic cancer	0.000484	0.000913	CcSEcCtD
Rizatriptan—Rash—Sunitinib—pancreatic cancer	0.000483	0.000911	CcSEcCtD
Rizatriptan—Dermatitis—Sunitinib—pancreatic cancer	0.000483	0.00091	CcSEcCtD
Rizatriptan—Abdominal distension—Doxorubicin—pancreatic cancer	0.000482	0.000909	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000481	0.000907	CcSEcCtD
Rizatriptan—Urticaria—Fluorouracil—pancreatic cancer	0.00048	0.000906	CcSEcCtD
Rizatriptan—Headache—Sunitinib—pancreatic cancer	0.00048	0.000905	CcSEcCtD
Rizatriptan—Syncope—Docetaxel—pancreatic cancer	0.000479	0.000904	CcSEcCtD
Rizatriptan—Dysphagia—Doxorubicin—pancreatic cancer	0.000479	0.000903	CcSEcCtD
Rizatriptan—Pollakiuria—Epirubicin—pancreatic cancer	0.000478	0.000902	CcSEcCtD
Rizatriptan—Body temperature increased—Fluorouracil—pancreatic cancer	0.000478	0.000901	CcSEcCtD
Rizatriptan—Palpitations—Docetaxel—pancreatic cancer	0.000472	0.000891	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000472	0.000891	CcSEcCtD
Rizatriptan—Loss of consciousness—Docetaxel—pancreatic cancer	0.00047	0.000886	CcSEcCtD
Rizatriptan—Cough—Docetaxel—pancreatic cancer	0.000466	0.00088	CcSEcCtD
Rizatriptan—Angina pectoris—Doxorubicin—pancreatic cancer	0.000466	0.00088	CcSEcCtD
Rizatriptan—Hypersensitivity—Irinotecan—pancreatic cancer	0.000465	0.000877	CcSEcCtD
Rizatriptan—Convulsion—Docetaxel—pancreatic cancer	0.000463	0.000874	CcSEcCtD
Rizatriptan—Hypertension—Docetaxel—pancreatic cancer	0.000461	0.00087	CcSEcCtD
Rizatriptan—Myalgia—Docetaxel—pancreatic cancer	0.000455	0.000858	CcSEcCtD
Rizatriptan—Arthralgia—Docetaxel—pancreatic cancer	0.000455	0.000858	CcSEcCtD
Rizatriptan—Chest pain—Docetaxel—pancreatic cancer	0.000455	0.000858	CcSEcCtD
Rizatriptan—Nausea—Sunitinib—pancreatic cancer	0.000455	0.000858	CcSEcCtD
Rizatriptan—Asthenia—Irinotecan—pancreatic cancer	0.000453	0.000854	CcSEcCtD
Rizatriptan—Dysuria—Doxorubicin—pancreatic cancer	0.000448	0.000844	CcSEcCtD
Rizatriptan—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000445	0.00084	CcSEcCtD
Rizatriptan—Dry mouth—Docetaxel—pancreatic cancer	0.000445	0.000839	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000445	0.000839	CcSEcCtD
Rizatriptan—Sweating—Epirubicin—pancreatic cancer	0.000442	0.000834	CcSEcCtD
Rizatriptan—Pollakiuria—Doxorubicin—pancreatic cancer	0.000442	0.000834	CcSEcCtD
Rizatriptan—Asthenia—Gemcitabine—pancreatic cancer	0.000441	0.000832	CcSEcCtD
Rizatriptan—Confusional state—Docetaxel—pancreatic cancer	0.00044	0.00083	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000437	0.000824	CcSEcCtD
Rizatriptan—Oedema—Docetaxel—pancreatic cancer	0.000436	0.000823	CcSEcCtD
Rizatriptan—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000436	0.000823	CcSEcCtD
Rizatriptan—Epistaxis—Epirubicin—pancreatic cancer	0.000435	0.000821	CcSEcCtD
Rizatriptan—Pruritus—Gemcitabine—pancreatic cancer	0.000435	0.00082	CcSEcCtD
Rizatriptan—Diarrhoea—Irinotecan—pancreatic cancer	0.000432	0.000814	CcSEcCtD
Rizatriptan—Shock—Docetaxel—pancreatic cancer	0.000429	0.00081	CcSEcCtD
Rizatriptan—Nervous system disorder—Docetaxel—pancreatic cancer	0.000428	0.000807	CcSEcCtD
Rizatriptan—Pruritus—Fluorouracil—pancreatic cancer	0.000428	0.000807	CcSEcCtD
Rizatriptan—Tachycardia—Docetaxel—pancreatic cancer	0.000426	0.000803	CcSEcCtD
Rizatriptan—Bradycardia—Epirubicin—pancreatic cancer	0.000422	0.000795	CcSEcCtD
Rizatriptan—Diarrhoea—Gemcitabine—pancreatic cancer	0.000421	0.000793	CcSEcCtD
Rizatriptan—Dizziness—Irinotecan—pancreatic cancer	0.000417	0.000787	CcSEcCtD
Rizatriptan—Anorexia—Docetaxel—pancreatic cancer	0.000416	0.000784	CcSEcCtD
Rizatriptan—Diarrhoea—Fluorouracil—pancreatic cancer	0.000414	0.00078	CcSEcCtD
Rizatriptan—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000412	0.000777	CcSEcCtD
Rizatriptan—Pharyngitis—Epirubicin—pancreatic cancer	0.000411	0.000775	CcSEcCtD
Rizatriptan—Sweating—Doxorubicin—pancreatic cancer	0.000409	0.000772	CcSEcCtD
Rizatriptan—Epistaxis—Doxorubicin—pancreatic cancer	0.000403	0.000759	CcSEcCtD
Rizatriptan—Vomiting—Irinotecan—pancreatic cancer	0.000401	0.000757	CcSEcCtD
Rizatriptan—Dizziness—Fluorouracil—pancreatic cancer	0.0004	0.000754	CcSEcCtD
Rizatriptan—Rash—Irinotecan—pancreatic cancer	0.000398	0.000751	CcSEcCtD
Rizatriptan—Dermatitis—Irinotecan—pancreatic cancer	0.000398	0.00075	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000397	0.00075	CcSEcCtD
Rizatriptan—Headache—Irinotecan—pancreatic cancer	0.000395	0.000746	CcSEcCtD
Rizatriptan—Insomnia—Docetaxel—pancreatic cancer	0.000395	0.000744	CcSEcCtD
Rizatriptan—Paraesthesia—Docetaxel—pancreatic cancer	0.000392	0.000739	CcSEcCtD
Rizatriptan—Vomiting—Gemcitabine—pancreatic cancer	0.000391	0.000737	CcSEcCtD
Rizatriptan—Bradycardia—Doxorubicin—pancreatic cancer	0.00039	0.000736	CcSEcCtD
Rizatriptan—Dyspnoea—Docetaxel—pancreatic cancer	0.000389	0.000734	CcSEcCtD
Rizatriptan—Somnolence—Docetaxel—pancreatic cancer	0.000388	0.000732	CcSEcCtD
Rizatriptan—Rash—Gemcitabine—pancreatic cancer	0.000388	0.000731	CcSEcCtD
Rizatriptan—Dermatitis—Gemcitabine—pancreatic cancer	0.000387	0.00073	CcSEcCtD
Rizatriptan—Tinnitus—Epirubicin—pancreatic cancer	0.000386	0.000728	CcSEcCtD
Rizatriptan—Headache—Gemcitabine—pancreatic cancer	0.000385	0.000726	CcSEcCtD
Rizatriptan—Flushing—Epirubicin—pancreatic cancer	0.000384	0.000725	CcSEcCtD
Rizatriptan—Vomiting—Fluorouracil—pancreatic cancer	0.000384	0.000725	CcSEcCtD
Rizatriptan—Dyspepsia—Docetaxel—pancreatic cancer	0.000384	0.000724	CcSEcCtD
Rizatriptan—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000381	0.000719	CcSEcCtD
Rizatriptan—Rash—Fluorouracil—pancreatic cancer	0.000381	0.000719	CcSEcCtD
Rizatriptan—Dermatitis—Fluorouracil—pancreatic cancer	0.000381	0.000718	CcSEcCtD
Rizatriptan—Pharyngitis—Doxorubicin—pancreatic cancer	0.00038	0.000717	CcSEcCtD
Rizatriptan—Decreased appetite—Docetaxel—pancreatic cancer	0.000379	0.000715	CcSEcCtD
Rizatriptan—Headache—Fluorouracil—pancreatic cancer	0.000379	0.000714	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000377	0.00071	CcSEcCtD
Rizatriptan—Fatigue—Docetaxel—pancreatic cancer	0.000376	0.000709	CcSEcCtD
Rizatriptan—Angiopathy—Epirubicin—pancreatic cancer	0.000376	0.000709	CcSEcCtD
Rizatriptan—Nausea—Irinotecan—pancreatic cancer	0.000375	0.000707	CcSEcCtD
Rizatriptan—Constipation—Docetaxel—pancreatic cancer	0.000373	0.000704	CcSEcCtD
Rizatriptan—Pain—Docetaxel—pancreatic cancer	0.000373	0.000704	CcSEcCtD
Rizatriptan—Chills—Epirubicin—pancreatic cancer	0.000372	0.000701	CcSEcCtD
Rizatriptan—Arrhythmia—Epirubicin—pancreatic cancer	0.00037	0.000698	CcSEcCtD
Rizatriptan—Nausea—Gemcitabine—pancreatic cancer	0.000365	0.000689	CcSEcCtD
Rizatriptan—Mental disorder—Epirubicin—pancreatic cancer	0.000363	0.000684	CcSEcCtD
Rizatriptan—Erythema—Epirubicin—pancreatic cancer	0.000361	0.00068	CcSEcCtD
Rizatriptan—Feeling abnormal—Docetaxel—pancreatic cancer	0.000359	0.000678	CcSEcCtD
Rizatriptan—Nausea—Fluorouracil—pancreatic cancer	0.000359	0.000677	CcSEcCtD
Rizatriptan—Tinnitus—Doxorubicin—pancreatic cancer	0.000357	0.000674	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000357	0.000673	CcSEcCtD
Rizatriptan—Flushing—Doxorubicin—pancreatic cancer	0.000356	0.000671	CcSEcCtD
Rizatriptan—Flatulence—Epirubicin—pancreatic cancer	0.000355	0.00067	CcSEcCtD
Rizatriptan—Tension—Epirubicin—pancreatic cancer	0.000354	0.000667	CcSEcCtD
Rizatriptan—Dysgeusia—Epirubicin—pancreatic cancer	0.000353	0.000666	CcSEcCtD
Rizatriptan—Nervousness—Epirubicin—pancreatic cancer	0.00035	0.000661	CcSEcCtD
Rizatriptan—Angiopathy—Doxorubicin—pancreatic cancer	0.000348	0.000656	CcSEcCtD
Rizatriptan—Muscle spasms—Epirubicin—pancreatic cancer	0.000347	0.000654	CcSEcCtD
Rizatriptan—Abdominal pain—Docetaxel—pancreatic cancer	0.000345	0.00065	CcSEcCtD
Rizatriptan—Body temperature increased—Docetaxel—pancreatic cancer	0.000345	0.00065	CcSEcCtD
Rizatriptan—Chills—Doxorubicin—pancreatic cancer	0.000344	0.000649	CcSEcCtD
Rizatriptan—Arrhythmia—Doxorubicin—pancreatic cancer	0.000342	0.000646	CcSEcCtD
Rizatriptan—Vision blurred—Epirubicin—pancreatic cancer	0.00034	0.000641	CcSEcCtD
Rizatriptan—Mental disorder—Doxorubicin—pancreatic cancer	0.000336	0.000633	CcSEcCtD
Rizatriptan—Erythema—Doxorubicin—pancreatic cancer	0.000334	0.000629	CcSEcCtD
Rizatriptan—Agitation—Epirubicin—pancreatic cancer	0.000331	0.000625	CcSEcCtD
Rizatriptan—Flatulence—Doxorubicin—pancreatic cancer	0.000329	0.00062	CcSEcCtD
Rizatriptan—Tension—Doxorubicin—pancreatic cancer	0.000327	0.000617	CcSEcCtD
Rizatriptan—Dysgeusia—Doxorubicin—pancreatic cancer	0.000327	0.000616	CcSEcCtD
Rizatriptan—Nervousness—Doxorubicin—pancreatic cancer	0.000324	0.000611	CcSEcCtD
Rizatriptan—Vertigo—Epirubicin—pancreatic cancer	0.000324	0.000611	CcSEcCtD
Rizatriptan—Syncope—Epirubicin—pancreatic cancer	0.000323	0.00061	CcSEcCtD
Rizatriptan—Hypersensitivity—Docetaxel—pancreatic cancer	0.000321	0.000606	CcSEcCtD
Rizatriptan—Muscle spasms—Doxorubicin—pancreatic cancer	0.000321	0.000605	CcSEcCtD
Rizatriptan—Palpitations—Epirubicin—pancreatic cancer	0.000319	0.000601	CcSEcCtD
Rizatriptan—Loss of consciousness—Epirubicin—pancreatic cancer	0.000317	0.000598	CcSEcCtD
Rizatriptan—Cough—Epirubicin—pancreatic cancer	0.000315	0.000593	CcSEcCtD
Rizatriptan—Vision blurred—Doxorubicin—pancreatic cancer	0.000314	0.000593	CcSEcCtD
Rizatriptan—Asthenia—Docetaxel—pancreatic cancer	0.000313	0.00059	CcSEcCtD
Rizatriptan—Convulsion—Epirubicin—pancreatic cancer	0.000312	0.000589	CcSEcCtD
Rizatriptan—Hypertension—Epirubicin—pancreatic cancer	0.000311	0.000587	CcSEcCtD
Rizatriptan—Pruritus—Docetaxel—pancreatic cancer	0.000309	0.000582	CcSEcCtD
Rizatriptan—Arthralgia—Epirubicin—pancreatic cancer	0.000307	0.000579	CcSEcCtD
Rizatriptan—Chest pain—Epirubicin—pancreatic cancer	0.000307	0.000579	CcSEcCtD
Rizatriptan—Myalgia—Epirubicin—pancreatic cancer	0.000307	0.000579	CcSEcCtD
Rizatriptan—Agitation—Doxorubicin—pancreatic cancer	0.000307	0.000578	CcSEcCtD
Rizatriptan—Anxiety—Epirubicin—pancreatic cancer	0.000306	0.000577	CcSEcCtD
Rizatriptan—Discomfort—Epirubicin—pancreatic cancer	0.000303	0.000572	CcSEcCtD
Rizatriptan—Dry mouth—Epirubicin—pancreatic cancer	0.0003	0.000566	CcSEcCtD
Rizatriptan—Vertigo—Doxorubicin—pancreatic cancer	0.0003	0.000565	CcSEcCtD
Rizatriptan—Syncope—Doxorubicin—pancreatic cancer	0.000299	0.000564	CcSEcCtD
Rizatriptan—Diarrhoea—Docetaxel—pancreatic cancer	0.000298	0.000563	CcSEcCtD
Rizatriptan—Confusional state—Epirubicin—pancreatic cancer	0.000297	0.00056	CcSEcCtD
Rizatriptan—Palpitations—Doxorubicin—pancreatic cancer	0.000295	0.000556	CcSEcCtD
Rizatriptan—Oedema—Epirubicin—pancreatic cancer	0.000294	0.000555	CcSEcCtD
Rizatriptan—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000294	0.000555	CcSEcCtD
Rizatriptan—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000293	0.000553	CcSEcCtD
Rizatriptan—Cough—Doxorubicin—pancreatic cancer	0.000291	0.000549	CcSEcCtD
Rizatriptan—Shock—Epirubicin—pancreatic cancer	0.000289	0.000546	CcSEcCtD
Rizatriptan—Convulsion—Doxorubicin—pancreatic cancer	0.000289	0.000545	CcSEcCtD
Rizatriptan—Nervous system disorder—Epirubicin—pancreatic cancer	0.000289	0.000544	CcSEcCtD
Rizatriptan—Dizziness—Docetaxel—pancreatic cancer	0.000288	0.000544	CcSEcCtD
Rizatriptan—Hypertension—Doxorubicin—pancreatic cancer	0.000288	0.000543	CcSEcCtD
Rizatriptan—Tachycardia—Epirubicin—pancreatic cancer	0.000287	0.000542	CcSEcCtD
Rizatriptan—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000284	0.000537	CcSEcCtD
Rizatriptan—Chest pain—Doxorubicin—pancreatic cancer	0.000284	0.000536	CcSEcCtD
Rizatriptan—Myalgia—Doxorubicin—pancreatic cancer	0.000284	0.000536	CcSEcCtD
Rizatriptan—Arthralgia—Doxorubicin—pancreatic cancer	0.000284	0.000536	CcSEcCtD
Rizatriptan—Anxiety—Doxorubicin—pancreatic cancer	0.000283	0.000534	CcSEcCtD
Rizatriptan—Discomfort—Doxorubicin—pancreatic cancer	0.000281	0.000529	CcSEcCtD
Rizatriptan—Anorexia—Epirubicin—pancreatic cancer	0.00028	0.000529	CcSEcCtD
Rizatriptan—Dry mouth—Doxorubicin—pancreatic cancer	0.000278	0.000524	CcSEcCtD
Rizatriptan—Vomiting—Docetaxel—pancreatic cancer	0.000277	0.000523	CcSEcCtD
Rizatriptan—Rash—Docetaxel—pancreatic cancer	0.000275	0.000519	CcSEcCtD
Rizatriptan—Dermatitis—Docetaxel—pancreatic cancer	0.000275	0.000518	CcSEcCtD
Rizatriptan—Confusional state—Doxorubicin—pancreatic cancer	0.000274	0.000518	CcSEcCtD
Rizatriptan—Headache—Docetaxel—pancreatic cancer	0.000273	0.000515	CcSEcCtD
Rizatriptan—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000272	0.000514	CcSEcCtD
Rizatriptan—Oedema—Doxorubicin—pancreatic cancer	0.000272	0.000514	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000268	0.000506	CcSEcCtD
Rizatriptan—Shock—Doxorubicin—pancreatic cancer	0.000268	0.000505	CcSEcCtD
Rizatriptan—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000267	0.000504	CcSEcCtD
Rizatriptan—Insomnia—Epirubicin—pancreatic cancer	0.000266	0.000502	CcSEcCtD
Rizatriptan—Tachycardia—Doxorubicin—pancreatic cancer	0.000266	0.000501	CcSEcCtD
Rizatriptan—Paraesthesia—Epirubicin—pancreatic cancer	0.000264	0.000498	CcSEcCtD
Rizatriptan—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000263	0.000496	CcSEcCtD
Rizatriptan—Dyspnoea—Epirubicin—pancreatic cancer	0.000262	0.000495	CcSEcCtD
Rizatriptan—Somnolence—Epirubicin—pancreatic cancer	0.000262	0.000493	CcSEcCtD
Rizatriptan—Anorexia—Doxorubicin—pancreatic cancer	0.000259	0.00049	CcSEcCtD
Rizatriptan—Nausea—Docetaxel—pancreatic cancer	0.000259	0.000489	CcSEcCtD
Rizatriptan—Dyspepsia—Epirubicin—pancreatic cancer	0.000259	0.000489	CcSEcCtD
Rizatriptan—Decreased appetite—Epirubicin—pancreatic cancer	0.000256	0.000482	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000254	0.000479	CcSEcCtD
Rizatriptan—Fatigue—Epirubicin—pancreatic cancer	0.000254	0.000479	CcSEcCtD
Rizatriptan—Constipation—Epirubicin—pancreatic cancer	0.000252	0.000475	CcSEcCtD
Rizatriptan—Pain—Epirubicin—pancreatic cancer	0.000252	0.000475	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000248	0.000468	CcSEcCtD
Rizatriptan—Insomnia—Doxorubicin—pancreatic cancer	0.000246	0.000464	CcSEcCtD
Rizatriptan—Paraesthesia—Doxorubicin—pancreatic cancer	0.000244	0.000461	CcSEcCtD
Rizatriptan—Dyspnoea—Doxorubicin—pancreatic cancer	0.000243	0.000458	CcSEcCtD
Rizatriptan—Feeling abnormal—Epirubicin—pancreatic cancer	0.000242	0.000457	CcSEcCtD
Rizatriptan—Somnolence—Doxorubicin—pancreatic cancer	0.000242	0.000457	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000241	0.000454	CcSEcCtD
Rizatriptan—Dyspepsia—Doxorubicin—pancreatic cancer	0.00024	0.000452	CcSEcCtD
Rizatriptan—Decreased appetite—Doxorubicin—pancreatic cancer	0.000237	0.000446	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000235	0.000443	CcSEcCtD
Rizatriptan—Fatigue—Doxorubicin—pancreatic cancer	0.000235	0.000443	CcSEcCtD
Rizatriptan—Urticaria—Epirubicin—pancreatic cancer	0.000234	0.000441	CcSEcCtD
Rizatriptan—Pain—Doxorubicin—pancreatic cancer	0.000233	0.000439	CcSEcCtD
Rizatriptan—Constipation—Doxorubicin—pancreatic cancer	0.000233	0.000439	CcSEcCtD
Rizatriptan—Abdominal pain—Epirubicin—pancreatic cancer	0.000233	0.000439	CcSEcCtD
Rizatriptan—Body temperature increased—Epirubicin—pancreatic cancer	0.000233	0.000439	CcSEcCtD
Rizatriptan—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000224	0.000423	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000223	0.00042	CcSEcCtD
Rizatriptan—Hypersensitivity—Epirubicin—pancreatic cancer	0.000217	0.000409	CcSEcCtD
Rizatriptan—Urticaria—Doxorubicin—pancreatic cancer	0.000216	0.000408	CcSEcCtD
Rizatriptan—Abdominal pain—Doxorubicin—pancreatic cancer	0.000215	0.000406	CcSEcCtD
Rizatriptan—Body temperature increased—Doxorubicin—pancreatic cancer	0.000215	0.000406	CcSEcCtD
Rizatriptan—Asthenia—Epirubicin—pancreatic cancer	0.000211	0.000398	CcSEcCtD
Rizatriptan—Pruritus—Epirubicin—pancreatic cancer	0.000208	0.000393	CcSEcCtD
Rizatriptan—Diarrhoea—Epirubicin—pancreatic cancer	0.000201	0.00038	CcSEcCtD
Rizatriptan—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000201	0.000378	CcSEcCtD
Rizatriptan—Asthenia—Doxorubicin—pancreatic cancer	0.000195	0.000368	CcSEcCtD
Rizatriptan—Dizziness—Epirubicin—pancreatic cancer	0.000195	0.000367	CcSEcCtD
Rizatriptan—Pruritus—Doxorubicin—pancreatic cancer	0.000193	0.000363	CcSEcCtD
Rizatriptan—Vomiting—Epirubicin—pancreatic cancer	0.000187	0.000353	CcSEcCtD
Rizatriptan—Diarrhoea—Doxorubicin—pancreatic cancer	0.000186	0.000351	CcSEcCtD
Rizatriptan—Rash—Epirubicin—pancreatic cancer	0.000186	0.00035	CcSEcCtD
Rizatriptan—Dermatitis—Epirubicin—pancreatic cancer	0.000185	0.00035	CcSEcCtD
Rizatriptan—Headache—Epirubicin—pancreatic cancer	0.000184	0.000348	CcSEcCtD
Rizatriptan—Dizziness—Doxorubicin—pancreatic cancer	0.00018	0.00034	CcSEcCtD
Rizatriptan—Nausea—Epirubicin—pancreatic cancer	0.000175	0.00033	CcSEcCtD
Rizatriptan—Vomiting—Doxorubicin—pancreatic cancer	0.000173	0.000327	CcSEcCtD
Rizatriptan—Rash—Doxorubicin—pancreatic cancer	0.000172	0.000324	CcSEcCtD
Rizatriptan—Dermatitis—Doxorubicin—pancreatic cancer	0.000171	0.000323	CcSEcCtD
Rizatriptan—Headache—Doxorubicin—pancreatic cancer	0.000171	0.000322	CcSEcCtD
Rizatriptan—Nausea—Doxorubicin—pancreatic cancer	0.000162	0.000305	CcSEcCtD
Rizatriptan—HTR1A—Signaling Pathways—CCK—pancreatic cancer	8.66e-05	0.000419	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TERT—pancreatic cancer	8.64e-05	0.000418	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SST—pancreatic cancer	8.62e-05	0.000417	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—JAG1—pancreatic cancer	8.61e-05	0.000416	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CD44—pancreatic cancer	8.59e-05	0.000415	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOTCH3—pancreatic cancer	8.58e-05	0.000415	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	8.5e-05	0.000411	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CNR2—pancreatic cancer	8.44e-05	0.000408	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GLP1R—pancreatic cancer	8.44e-05	0.000408	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CXCL8—pancreatic cancer	8.44e-05	0.000408	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—JAG1—pancreatic cancer	8.43e-05	0.000408	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOTCH3—pancreatic cancer	8.4e-05	0.000406	CbGpPWpGaD
Rizatriptan—MAOA—Neuronal System—HRAS—pancreatic cancer	8.39e-05	0.000405	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCKAR—pancreatic cancer	8.3e-05	0.000402	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HIF1A—pancreatic cancer	8.27e-05	0.0004	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TSC2—pancreatic cancer	8.24e-05	0.000399	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GCG—pancreatic cancer	8.23e-05	0.000398	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CNR1—pancreatic cancer	8.12e-05	0.000393	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—APOE—pancreatic cancer	8.07e-05	0.00039	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JAG2—pancreatic cancer	8.05e-05	0.000389	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CNR1—pancreatic cancer	7.95e-05	0.000385	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MEN1—pancreatic cancer	7.94e-05	0.000384	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KDR—pancreatic cancer	7.9e-05	0.000382	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CG—pancreatic cancer	7.88e-05	0.000381	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GCG—pancreatic cancer	7.84e-05	0.000379	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—STK11—pancreatic cancer	7.74e-05	0.000374	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CG—pancreatic cancer	7.72e-05	0.000373	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GCG—pancreatic cancer	7.68e-05	0.000371	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.63e-05	0.000369	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SHH—pancreatic cancer	7.57e-05	0.000366	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH4—pancreatic cancer	7.52e-05	0.000364	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NFKBIA—pancreatic cancer	7.52e-05	0.000364	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AGTR1—pancreatic cancer	7.48e-05	0.000362	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IAPP—pancreatic cancer	7.48e-05	0.000362	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.47e-05	0.000361	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NOTCH1—pancreatic cancer	7.45e-05	0.00036	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—STK11—pancreatic cancer	7.38e-05	0.000357	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AGTR1—pancreatic cancer	7.33e-05	0.000354	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CG—pancreatic cancer	7.28e-05	0.000352	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—NRAS—pancreatic cancer	7.28e-05	0.000352	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—STK11—pancreatic cancer	7.22e-05	0.000349	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EGF—pancreatic cancer	7.2e-05	0.000348	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTCH1—pancreatic cancer	7.18e-05	0.000347	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTHLH—pancreatic cancer	7.18e-05	0.000347	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PRSS1—pancreatic cancer	7.17e-05	0.000347	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CD—pancreatic cancer	6.93e-05	0.000335	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CD—pancreatic cancer	6.79e-05	0.000328	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—TYMS—pancreatic cancer	6.66e-05	0.000322	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.65e-05	0.000322	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—EGFR—pancreatic cancer	6.63e-05	0.000321	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SST—pancreatic cancer	6.56e-05	0.000317	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.51e-05	0.000315	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.47e-05	0.000313	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SMAD4—pancreatic cancer	6.46e-05	0.000312	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JAG1—pancreatic cancer	6.42e-05	0.000311	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CD—pancreatic cancer	6.4e-05	0.00031	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH3—pancreatic cancer	6.4e-05	0.000309	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCL8—pancreatic cancer	6.39e-05	0.000309	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.34e-05	0.000307	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SMAD4—pancreatic cancer	6.33e-05	0.000306	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HES1—pancreatic cancer	6.31e-05	0.000305	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—KRAS—pancreatic cancer	6.27e-05	0.000303	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCL8—pancreatic cancer	6.26e-05	0.000303	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ARG2—pancreatic cancer	6.22e-05	0.000301	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HES1—pancreatic cancer	6.18e-05	0.000299	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CNR1—pancreatic cancer	6.06e-05	0.000293	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CB—pancreatic cancer	6.04e-05	0.000292	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CB—pancreatic cancer	5.91e-05	0.000286	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CG—pancreatic cancer	5.88e-05	0.000284	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GCG—pancreatic cancer	5.85e-05	0.000283	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCL8—pancreatic cancer	5.8e-05	0.000281	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—PIK3CA—pancreatic cancer	5.76e-05	0.000278	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.69e-05	0.000275	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCL8—pancreatic cancer	5.68e-05	0.000275	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AGTR1—pancreatic cancer	5.58e-05	0.00027	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CB—pancreatic cancer	5.58e-05	0.00027	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TERT—pancreatic cancer	5.53e-05	0.000267	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—STK11—pancreatic cancer	5.5e-05	0.000266	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TYMP—pancreatic cancer	5.43e-05	0.000263	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOE—pancreatic cancer	5.41e-05	0.000262	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TERT—pancreatic cancer	5.41e-05	0.000262	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL8—pancreatic cancer	5.36e-05	0.000259	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—HRAS—pancreatic cancer	5.33e-05	0.000258	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HIF1A—pancreatic cancer	5.29e-05	0.000256	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TSC2—pancreatic cancer	5.27e-05	0.000255	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AKT1—pancreatic cancer	5.18e-05	0.00025	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HIF1A—pancreatic cancer	5.18e-05	0.00025	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	5.17e-05	0.00025	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TSC2—pancreatic cancer	5.16e-05	0.00025	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOE—pancreatic cancer	5.16e-05	0.000249	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CASP3—pancreatic cancer	5.13e-05	0.000248	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KDR—pancreatic cancer	5.05e-05	0.000244	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOE—pancreatic cancer	5.05e-05	0.000244	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCND1—pancreatic cancer	5e-05	0.000242	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.96e-05	0.00024	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KDR—pancreatic cancer	4.95e-05	0.000239	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CTNNB1—pancreatic cancer	4.95e-05	0.000239	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CG—pancreatic cancer	4.89e-05	0.000236	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP9—pancreatic cancer	4.85e-05	0.000234	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PTEN—pancreatic cancer	4.82e-05	0.000233	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SMAD4—pancreatic cancer	4.82e-05	0.000233	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NFKBIA—pancreatic cancer	4.81e-05	0.000232	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	4.77e-05	0.000231	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOTCH1—pancreatic cancer	4.76e-05	0.00023	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARG—pancreatic cancer	4.72e-05	0.000228	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NFKBIA—pancreatic cancer	4.71e-05	0.000228	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HES1—pancreatic cancer	4.7e-05	0.000227	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AKT1—pancreatic cancer	4.7e-05	0.000227	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOTCH1—pancreatic cancer	4.66e-05	0.000225	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CG—pancreatic cancer	4.66e-05	0.000225	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—NRAS—pancreatic cancer	4.66e-05	0.000225	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGF—pancreatic cancer	4.6e-05	0.000223	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CG—pancreatic cancer	4.56e-05	0.00022	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—NRAS—pancreatic cancer	4.56e-05	0.00022	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGF—pancreatic cancer	4.51e-05	0.000218	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	4.51e-05	0.000218	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.48e-05	0.000217	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SRC—pancreatic cancer	4.47e-05	0.000216	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GLP1R—pancreatic cancer	4.38e-05	0.000212	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—pancreatic cancer	4.35e-05	0.000211	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL8—pancreatic cancer	4.33e-05	0.000209	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—STAT3—pancreatic cancer	4.31e-05	0.000208	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—DPYD—pancreatic cancer	4.31e-05	0.000208	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NRAS—pancreatic cancer	4.3e-05	0.000208	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CD—pancreatic cancer	4.3e-05	0.000208	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EGFR—pancreatic cancer	4.24e-05	0.000205	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EGFR—pancreatic cancer	4.15e-05	0.000201	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TERT—pancreatic cancer	4.12e-05	0.000199	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CD—pancreatic cancer	4.09e-05	0.000198	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	4.09e-05	0.000198	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.05e-05	0.000196	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.05e-05	0.000196	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CD—pancreatic cancer	4.01e-05	0.000194	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—KRAS—pancreatic cancer	4.01e-05	0.000194	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MYC—pancreatic cancer	4.01e-05	0.000194	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TGFB1—pancreatic cancer	4e-05	0.000193	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.97e-05	0.000192	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HIF1A—pancreatic cancer	3.94e-05	0.000191	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TSC2—pancreatic cancer	3.93e-05	0.00019	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—KRAS—pancreatic cancer	3.92e-05	0.00019	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EGFR—pancreatic cancer	3.92e-05	0.000189	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.91e-05	0.000189	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOE—pancreatic cancer	3.85e-05	0.000186	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KDR—pancreatic cancer	3.77e-05	0.000182	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CB—pancreatic cancer	3.74e-05	0.000181	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—pancreatic cancer	3.71e-05	0.000179	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KRAS—pancreatic cancer	3.7e-05	0.000179	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CA—pancreatic cancer	3.68e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CA—pancreatic cancer	3.61e-05	0.000174	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NFKBIA—pancreatic cancer	3.59e-05	0.000173	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CB—pancreatic cancer	3.57e-05	0.000173	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.56e-05	0.000172	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH1—pancreatic cancer	3.55e-05	0.000172	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CB—pancreatic cancer	3.49e-05	0.000169	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CG—pancreatic cancer	3.47e-05	0.000168	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—NRAS—pancreatic cancer	3.47e-05	0.000168	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGF—pancreatic cancer	3.43e-05	0.000166	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL8—pancreatic cancer	3.43e-05	0.000166	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HRAS—pancreatic cancer	3.41e-05	0.000165	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CA—pancreatic cancer	3.4e-05	0.000164	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL8—pancreatic cancer	3.36e-05	0.000162	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HRAS—pancreatic cancer	3.34e-05	0.000161	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT1—pancreatic cancer	3.31e-05	0.00016	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—pancreatic cancer	3.29e-05	0.000159	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CASP3—pancreatic cancer	3.28e-05	0.000159	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT1—pancreatic cancer	3.24e-05	0.000157	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTEN—pancreatic cancer	3.24e-05	0.000156	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CASP3—pancreatic cancer	3.21e-05	0.000155	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCND1—pancreatic cancer	3.19e-05	0.000154	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CD44—pancreatic cancer	3.17e-05	0.000153	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	3.16e-05	0.000153	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CTNNB1—pancreatic cancer	3.16e-05	0.000153	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HRAS—pancreatic cancer	3.15e-05	0.000152	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCND1—pancreatic cancer	3.13e-05	0.000151	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—pancreatic cancer	3.1e-05	0.00015	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.1e-05	0.00015	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CTNNB1—pancreatic cancer	3.1e-05	0.00015	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTEN—pancreatic cancer	3.08e-05	0.000149	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.07e-05	0.000149	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	3.05e-05	0.000148	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—pancreatic cancer	3.04e-05	0.000147	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GCG—pancreatic cancer	3.04e-05	0.000147	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.02e-05	0.000146	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTEN—pancreatic cancer	3.02e-05	0.000146	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT1—pancreatic cancer	3.01e-05	0.000145	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	2.99e-05	0.000145	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT1—pancreatic cancer	2.95e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SRC—pancreatic cancer	2.86e-05	0.000138	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—STK11—pancreatic cancer	2.85e-05	0.000138	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SRC—pancreatic cancer	2.8e-05	0.000135	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—pancreatic cancer	2.78e-05	0.000135	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT1—pancreatic cancer	2.78e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—STAT3—pancreatic cancer	2.76e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NRAS—pancreatic cancer	2.75e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.75e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—pancreatic cancer	2.73e-05	0.000132	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—STAT3—pancreatic cancer	2.7e-05	0.000131	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NRAS—pancreatic cancer	2.69e-05	0.00013	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.68e-05	0.00013	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	2.66e-05	0.000129	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MYC—pancreatic cancer	2.56e-05	0.000124	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	2.56e-05	0.000124	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TGFB1—pancreatic cancer	2.56e-05	0.000124	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	2.54e-05	0.000123	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MYC—pancreatic cancer	2.51e-05	0.000121	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGFR—pancreatic cancer	2.51e-05	0.000121	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TGFB1—pancreatic cancer	2.5e-05	0.000121	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	2.47e-05	0.000119	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.46e-05	0.000119	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGFR—pancreatic cancer	2.45e-05	0.000119	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	2.45e-05	0.000118	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	2.38e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KRAS—pancreatic cancer	2.37e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	2.36e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KRAS—pancreatic cancer	2.32e-05	0.000112	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	2.31e-05	0.000112	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	2.3e-05	0.000111	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CA—pancreatic cancer	2.28e-05	0.00011	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	2.24e-05	0.000108	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CA—pancreatic cancer	2.18e-05	0.000105	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SRC—pancreatic cancer	2.13e-05	0.000103	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	2.13e-05	0.000103	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—pancreatic cancer	2.1e-05	0.000102	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	2.08e-05	0.0001	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—pancreatic cancer	2.06e-05	9.96e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	2.06e-05	9.95e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	2.05e-05	9.92e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	2.01e-05	9.73e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOE—pancreatic cancer	2e-05	9.66e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	1.97e-05	9.53e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MYC—pancreatic cancer	1.91e-05	9.24e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	1.91e-05	9.22e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.89e-05	9.14e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	1.87e-05	9.04e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKT1—pancreatic cancer	1.86e-05	9.02e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.8e-05	8.71e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	1.78e-05	8.59e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	1.77e-05	8.54e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	1.74e-05	8.41e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.74e-05	8.41e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.62e-05	7.85e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.58e-05	7.66e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—pancreatic cancer	1.57e-05	7.59e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	1.5e-05	7.26e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.38e-05	6.68e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.37e-05	6.62e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	1.33e-05	6.41e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.19e-05	5.77e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	8.42e-06	4.07e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKT1—pancreatic cancer	6.88e-06	3.33e-05	CbGpPWpGaD
